Difference between revisions of "Template:Adrenergic receptor modulators"
Jump to navigation
Jump to search
blackwiki>AGK m (Protected Template:Adrenergics: Highly-visible template (TW) ([edit=autoconfirmed] (indefinite))) |
m (274 revisions imported) |
||
| (107 intermediate revisions by 31 users not shown) | |||
| Line 1: | Line 1: | ||
| − | {{Navbox | + | {{Navbox |
| − | | name | + | | name = Adrenergic receptor modulators |
| − | | title = [[Adrenergic]]s | + | | title = [[Adrenergic receptor]] [[receptor modulator|modulator]]s |
| − | | | + | | state = {{{state<includeonly>|collapsed</includeonly>}}} |
| − | | | + | | bodyclass = hlist |
| − | | | + | | selected = {{{selected|{{{1|}}}}}} |
| + | | border = {{{border|}}}<!-- for embedding in [[Template:Monoaminergics]] etc., or subst'd versions thereof --> | ||
| − | + | | group1 = [[Alpha-1 adrenergic receptor|α<sub>1</sub>]] | |
| − | + | | list1 = | |
| − | + | * ''Agonists:'' [[6-Fluoronorepinephrine|6-FNE]] | |
| − | |||
| − | |||
| − | |||
| − | * | ||
| − | |||
* [[Amidephrine]] | * [[Amidephrine]] | ||
| − | |||
* [[Anisodine]] | * [[Anisodine]] | ||
| + | * [[Buspirone]] | ||
* [[Cirazoline]] | * [[Cirazoline]] | ||
| + | * [[Corbadrine]] | ||
| + | * [[Desglymidodrine]] | ||
| + | * [[Dexisometheptene]] | ||
* [[Dipivefrine]] | * [[Dipivefrine]] | ||
* [[Dopamine]] | * [[Dopamine]] | ||
| + | * [[Droxidopa|Droxidopa (<small>L</small>-DOPS)]]<!--Prodrug--> | ||
* [[Ephedrine]] | * [[Ephedrine]] | ||
| − | * [[Epinephrine]] | + | * [[Epinephrine]] |
* [[Etilefrine]] | * [[Etilefrine]] | ||
| + | * [[Etilevodopa]]<!--Prodrug--> | ||
* [[Ethylnorepinephrine]] | * [[Ethylnorepinephrine]] | ||
* [[Indanidine]] | * [[Indanidine]] | ||
| − | * [[ | + | * [[Isometheptene]] |
| + | * [[L-DOPA|<small>L</small>-DOPA (levodopa)]]<!--Prodrug--> | ||
| + | * [[Phenylalanine|<small>L</small>-Phenylalanine]]<!--Prodrug--> | ||
| + | * [[Tyrosine|<small>L</small>-Tyrosine]]<!--Prodrug--> | ||
| + | * [[Melevodopa]]<!--Prodrug--> | ||
* [[Metaraminol]] | * [[Metaraminol]] | ||
* [[Methoxamine]] | * [[Methoxamine]] | ||
| Line 31: | Line 36: | ||
* [[Midodrine]] | * [[Midodrine]] | ||
* [[Naphazoline]] | * [[Naphazoline]] | ||
| − | * [[Norepinephrine]] | + | * [[Norepinephrine]] |
* [[Octopamine]] | * [[Octopamine]] | ||
* [[Oxymetazoline]] | * [[Oxymetazoline]] | ||
| Line 38: | Line 43: | ||
* [[Pseudoephedrine]] | * [[Pseudoephedrine]] | ||
* [[Synephrine]] | * [[Synephrine]] | ||
| − | * [[ | + | * [[Tetryzoline]] |
| + | * [[Tiamenidine]] | ||
| + | * [[XP21279]]<!--Prodrug--> | ||
| + | * [[Xylometazoline]] | ||
| + | |||
| + | * ''Antagonists:'' [[Abanoquil]] | ||
* [[Adimolol]] | * [[Adimolol]] | ||
* [[Ajmalicine]] | * [[Ajmalicine]] | ||
* [[Alfuzosin]] | * [[Alfuzosin]] | ||
* [[Amosulalol]] | * [[Amosulalol]] | ||
| + | * [[Anisodamine]] | ||
* [[Arotinolol]] | * [[Arotinolol]] | ||
* [[Atiprosin]] | * [[Atiprosin]] | ||
| + | * [[Atypical antipsychotic]]s (e.g., [[brexpiprazole]], [[clozapine]], [[olanzapine]], [[quetiapine]], [[risperidone]]) | ||
* [[Benoxathian]] | * [[Benoxathian]] | ||
* [[Buflomedil]] | * [[Buflomedil]] | ||
* [[Bunazosin]] | * [[Bunazosin]] | ||
* [[Carvedilol]] | * [[Carvedilol]] | ||
| − | |||
* [[Corynanthine]] | * [[Corynanthine]] | ||
* [[Dapiprazole]] | * [[Dapiprazole]] | ||
| − | |||
* [[Domesticine]] | * [[Domesticine]] | ||
* [[Doxazosin]] | * [[Doxazosin]] | ||
| + | * [[Ergoline]]s (e.g., [[ergotamine]], [[dihydroergotamine]], [[lisuride]], [[terguride]]) | ||
| + | * [[Etoperidone]] | ||
* [[Eugenodilol]] | * [[Eugenodilol]] | ||
* [[Fenspiride]] | * [[Fenspiride]] | ||
| − | * [[ | + | * [[Hydroxyzine]] |
| − | |||
* [[Indoramin]] | * [[Indoramin]] | ||
* [[Ketanserin]] | * [[Ketanserin]] | ||
* [[L-765,314]] | * [[L-765,314]] | ||
* [[Labetalol]] | * [[Labetalol]] | ||
| − | * [[ | + | * [[Meta-Chlorophenylpiperazine|mCPP]] |
| + | * [[Mepiprazole]] | ||
* [[Metazosin]] | * [[Metazosin]] | ||
* [[Monatepil]] | * [[Monatepil]] | ||
| − | * [[Moxisylyte]] | + | * [[Moxisylyte]] |
* [[Naftopidil]] | * [[Naftopidil]] | ||
* [[Nantenine]] | * [[Nantenine]] | ||
* [[Neldazosin]] | * [[Neldazosin]] | ||
| + | * [[Niaprazine]] | ||
* [[Nicergoline]] | * [[Nicergoline]] | ||
* [[Niguldipine]] | * [[Niguldipine]] | ||
| + | * [[Pardoprunox]] | ||
* [[Pelanserin]] | * [[Pelanserin]] | ||
| + | * [[Perlapine]] | ||
* [[Phendioxan]] | * [[Phendioxan]] | ||
* [[Phenoxybenzamine]] | * [[Phenoxybenzamine]] | ||
* [[Phentolamine]] | * [[Phentolamine]] | ||
| + | * [[Phenylpiperazine]] [[antidepressant]]s (e.g., [[hydroxynefazodone]], [[nefazodone]], [[trazodone]], [[triazoledione]]) | ||
* [[Piperoxan]] | * [[Piperoxan]] | ||
* [[Prazosin]] | * [[Prazosin]] | ||
* [[Quinazosin]] | * [[Quinazosin]] | ||
| + | * [[Quinidine]] | ||
* [[Ritanserin]] | * [[Ritanserin]] | ||
| − | |||
| − | |||
* [[Silodosin]] | * [[Silodosin]] | ||
| − | |||
* [[Spiperone]] | * [[Spiperone]] | ||
* [[Talipexole]] | * [[Talipexole]] | ||
* [[Tamsulosin]] | * [[Tamsulosin]] | ||
* [[Terazosin]] | * [[Terazosin]] | ||
| − | |||
* [[Tiodazosin]] | * [[Tiodazosin]] | ||
| − | |||
* [[Tolazoline]] | * [[Tolazoline]] | ||
| + | * [[Tetracyclic antidepressant]]s (e.g., [[amoxapine]], [[maprotiline]], [[mianserin]]) | ||
| + | * [[Tricyclic antidepressant]]s (e.g., [[amitriptyline]], [[clomipramine]], [[doxepin]], [[imipramine]], [[trimipramine]]) | ||
* [[Trimazosin]] | * [[Trimazosin]] | ||
| − | * [[ | + | * [[Typical antipsychotic]]s (e.g., [[chlorpromazine]], [[fluphenazine]], [[loxapine]], [[thioridazine]]) |
* [[Urapidil]] | * [[Urapidil]] | ||
| − | * [[ | + | * [[WB-4101]] |
| + | * [[Zolertine]] | ||
| − | + | | group2 = [[Alpha-2 adrenergic receptor|α<sub>2</sub>]] | |
| − | + | | list2 = | |
| − | * | + | * ''Agonists:'' [[(R)-3-Nitrobiphenyline]] |
* [[4-NEMD]] | * [[4-NEMD]] | ||
* [[6-Fluoronorepinephrine|6-FNE]] | * [[6-Fluoronorepinephrine|6-FNE]] | ||
| Line 107: | Line 122: | ||
* [[Cannabivarin]] | * [[Cannabivarin]] | ||
* [[Clonidine]] | * [[Clonidine]] | ||
| + | * [[Corbadrine]] | ||
* [[Detomidine]] | * [[Detomidine]] | ||
* [[Dexmedetomidine]] | * [[Dexmedetomidine]] | ||
| Line 112: | Line 128: | ||
* [[Dipivefrine]] | * [[Dipivefrine]] | ||
* [[Dopamine]] | * [[Dopamine]] | ||
| + | * [[Droxidopa|Droxidopa (<small>L</small>-DOPS)]]<!--Prodrug--> | ||
| + | * [[Etilevodopa]]<!--Prodrug--> | ||
* [[Ephedrine]] | * [[Ephedrine]] | ||
* [[Ergotamine]] | * [[Ergotamine]] | ||
| − | * [[Epinephrine | + | * [[Epinephrine]] |
| − | |||
* [[Etilefrine]] | * [[Etilefrine]] | ||
* [[Ethylnorepinephrine]] | * [[Ethylnorepinephrine]] | ||
| Line 121: | Line 138: | ||
* [[Guanfacine]] | * [[Guanfacine]] | ||
* [[Guanoxabenz]] | * [[Guanoxabenz]] | ||
| − | * [[ | + | * [[L-DOPA|<small>L</small>-DOPA (levodopa)]]<!--Prodrug--> |
| + | * [[Phenylalanine|<small>L</small>-Phenylalanine]]<!--Prodrug--> | ||
| + | * [[Tyrosine|<small>L</small>-Tyrosine]]<!--Prodrug--> | ||
* [[Lofexidine]] | * [[Lofexidine]] | ||
* [[Medetomidine]] | * [[Medetomidine]] | ||
| + | * [[Melevodopa]]<!--Prodrug--> | ||
* [[Methyldopa]] | * [[Methyldopa]] | ||
* [[Mivazerol]] | * [[Mivazerol]] | ||
* [[Naphazoline]] | * [[Naphazoline]] | ||
| − | * [[Norepinephrine]] | + | * [[Norepinephrine]] |
| + | * [[Oxymetazoline]] | ||
* [[Phenylpropanolamine]] | * [[Phenylpropanolamine]] | ||
* [[Piperoxan]] | * [[Piperoxan]] | ||
* [[Pseudoephedrine]] | * [[Pseudoephedrine]] | ||
| + | * [[Rezatomidine]] | ||
* [[Rilmenidine]] | * [[Rilmenidine]] | ||
* [[Romifidine]] | * [[Romifidine]] | ||
* [[Talipexole]] | * [[Talipexole]] | ||
| + | * [[Tasipimidine]] | ||
* [[Tetrahydrozoline]] | * [[Tetrahydrozoline]] | ||
| + | * [[Tiamenidine]] | ||
* [[Tizanidine]] | * [[Tizanidine]] | ||
* [[Tolonidine]] | * [[Tolonidine]] | ||
* [[Urapidil]] | * [[Urapidil]] | ||
| + | * [[Vatinoxan]] | ||
| + | * [[XP21279]]<!--Prodrug--> | ||
* [[Xylazine]] | * [[Xylazine]] | ||
| − | * [[Xylometazoline]] | + | * [[Xylometazoline]] |
| + | |||
| + | * ''Antagonists:'' [[Pyrimidinylpiperazine|1-PP]] | ||
* [[Adimolol]] | * [[Adimolol]] | ||
| + | * [[Amesergide]] | ||
* [[Aptazapine]] | * [[Aptazapine]] | ||
* [[Atipamezole]] | * [[Atipamezole]] | ||
| + | * [[Atypical antipsychotic]]s (e.g., [[asenapine]], [[brexpiprazole]], [[clozapine]], [[lurasidone]], [[olanzapine]], [[paliperidone]], [[quetiapine]], [[risperidone]], [[zotepine]]) | ||
| + | * [[Azapirone]]s (e.g., [[buspirone]], [[gepirone]], [[ipsapirone]], [[tandospirone]]) | ||
* [[BRL-44408]] | * [[BRL-44408]] | ||
* [[Buflomedil]] | * [[Buflomedil]] | ||
| Line 150: | Line 181: | ||
* [[Fenmetozole]] | * [[Fenmetozole]] | ||
* [[Fluparoxan]] | * [[Fluparoxan]] | ||
| − | |||
| − | |||
* [[Idazoxan]] | * [[Idazoxan]] | ||
| + | * [[Meta-Chlorophenylpiperazine|mCPP]] | ||
* [[Mianserin]] | * [[Mianserin]] | ||
* [[Mirtazapine]] | * [[Mirtazapine]] | ||
| − | |||
* [[NAN-190]] | * [[NAN-190]] | ||
| − | * [[ | + | * [[Pardoprunox]] |
* [[Phentolamine]] | * [[Phentolamine]] | ||
* [[Phenoxybenzamine]] | * [[Phenoxybenzamine]] | ||
| Line 164: | Line 193: | ||
* [[Rauwolscine]] | * [[Rauwolscine]] | ||
* [[Rotigotine]] | * [[Rotigotine]] | ||
| − | * [[SB- | + | * [[SB-269970]] |
* [[Setiptiline]] | * [[Setiptiline]] | ||
* [[Spiroxatrine]] | * [[Spiroxatrine]] | ||
* [[Sunepitron]] | * [[Sunepitron]] | ||
* [[Tolazoline]] | * [[Tolazoline]] | ||
| − | * [[ | + | * [[Typical antipsychotic]]s (e.g., [[chlorpromazine]], [[fluphenazine]], [[loxapine]], [[thioridazine]]) |
| + | * [[Yohimbine]] | ||
| − | + | | group3 = [[β-adrenergic receptor|β]] | |
| − | + | | list3 = | |
| − | * | + | * ''Agonists:'' [[Abediterol]] |
| − | * [[ | + | * [[Alifedrine]] |
* [[Amibegron]] | * [[Amibegron]] | ||
* [[Arbutamine]] | * [[Arbutamine]] | ||
| Line 186: | Line 216: | ||
* [[Buphenine]] | * [[Buphenine]] | ||
* [[Carbuterol]] | * [[Carbuterol]] | ||
| + | * [[Carmoterol]] | ||
* [[Cimaterol]] | * [[Cimaterol]] | ||
* [[Clenbuterol]] | * [[Clenbuterol]] | ||
| + | * [[Colterol]] | ||
| + | * [[Corbadrine]] | ||
* [[Denopamine]] | * [[Denopamine]] | ||
| − | |||
* [[Dipivefrine]] | * [[Dipivefrine]] | ||
* [[Dobutamine]] | * [[Dobutamine]] | ||
* [[Dopamine]] | * [[Dopamine]] | ||
* [[Dopexamine]] | * [[Dopexamine]] | ||
| + | * [[Droxidopa|Droxidopa (<small>L</small>-DOPS)]]<!--Prodrug--> | ||
* [[Ephedrine]] | * [[Ephedrine]] | ||
| − | * [[Epinephrine]] | + | * [[Epinephrine]] |
* [[Etafedrine]] | * [[Etafedrine]] | ||
* [[Etilefrine]] | * [[Etilefrine]] | ||
| + | * [[Etilevodopa]]<!--Prodrug--> | ||
* [[Ethylnorepinephrine]] | * [[Ethylnorepinephrine]] | ||
* [[Fenoterol]] | * [[Fenoterol]] | ||
| Line 205: | Line 239: | ||
* [[Indacaterol]] | * [[Indacaterol]] | ||
* [[Isoetarine]] | * [[Isoetarine]] | ||
| − | * [[Isoprenaline]] | + | * [[Isoprenaline]] |
* [[Isoxsuprine]] | * [[Isoxsuprine]] | ||
| − | * [[ | + | * [[L-DOPA|<small>L</small>-DOPA (levodopa)]]<!--Prodrug--> |
| − | * [[ | + | * [[Phenylalanine|<small>L</small>-Phenylalanine]]<!--Prodrug--> |
| + | * [[Tyrosine|<small>L</small>-Tyrosine]]<!--Prodrug--> | ||
* [[Levosalbutamol]] | * [[Levosalbutamol]] | ||
* [[Mabuterol]] | * [[Mabuterol]] | ||
| + | * [[Melevodopa]]<!--Prodrug--> | ||
* [[Methoxyphenamine]] | * [[Methoxyphenamine]] | ||
* [[Methyldopa]] | * [[Methyldopa]] | ||
| − | * [[ | + | * [[Mirabegron]] |
| − | * [[Norepinephrine]] | + | * [[Norepinephrine]] |
* [[Orciprenaline]] | * [[Orciprenaline]] | ||
* [[Oxyfedrine]] | * [[Oxyfedrine]] | ||
| + | * [[PF-610355]] | ||
* [[Phenylpropanolamine]] | * [[Phenylpropanolamine]] | ||
* [[Pirbuterol]] | * [[Pirbuterol]] | ||
| Line 226: | Line 263: | ||
* [[Rimiterol]] | * [[Rimiterol]] | ||
* [[Ritodrine]] | * [[Ritodrine]] | ||
| − | * [[Salbutamol]] | + | * [[Salbutamol]] |
* [[Salmeterol]] | * [[Salmeterol]] | ||
* [[Solabegron]] | * [[Solabegron]] | ||
| Line 232: | Line 269: | ||
* [[Tretoquinol]] | * [[Tretoquinol]] | ||
* [[Tulobuterol]] | * [[Tulobuterol]] | ||
| + | * [[Vilanterol]] | ||
* [[Xamoterol]] | * [[Xamoterol]] | ||
| + | * [[XP21279]]<!--Prodrug--> | ||
* [[Zilpaterol]] | * [[Zilpaterol]] | ||
| − | * [[Zinterol]] | + | * [[Zinterol]] |
| + | |||
| + | * ''Antagonists:'' [[Acebutolol]] | ||
* [[Adaprolol]] | * [[Adaprolol]] | ||
* [[Adimolol]] | * [[Adimolol]] | ||
| Line 250: | Line 291: | ||
* [[Bisoprolol]] | * [[Bisoprolol]] | ||
* [[Bopindolol]] | * [[Bopindolol]] | ||
| − | |||
* [[Bornaprolol]] | * [[Bornaprolol]] | ||
* [[Brefonalol]] | * [[Brefonalol]] | ||
| Line 256: | Line 296: | ||
* [[Bucumolol]] | * [[Bucumolol]] | ||
* [[Bufetolol]] | * [[Bufetolol]] | ||
| − | |||
* [[Bufuralol]] | * [[Bufuralol]] | ||
* [[Bunitrolol]] | * [[Bunitrolol]] | ||
* [[Bunolol]] | * [[Bunolol]] | ||
* [[Bupranolol]] | * [[Bupranolol]] | ||
| − | |||
* [[Butaxamine]] | * [[Butaxamine]] | ||
* [[Butidrine]] | * [[Butidrine]] | ||
| Line 284: | Line 322: | ||
* [[Diprafenone]] | * [[Diprafenone]] | ||
* [[Draquinolol]] | * [[Draquinolol]] | ||
| − | |||
* [[Ecastolol]] | * [[Ecastolol]] | ||
* [[Epanolol]] | * [[Epanolol]] | ||
| Line 290: | Line 327: | ||
* [[Ersentilide]] | * [[Ersentilide]] | ||
* [[Esatenolol]] | * [[Esatenolol]] | ||
| − | |||
* [[Esprolol]] | * [[Esprolol]] | ||
* [[Eugenodilol]] | * [[Eugenodilol]] | ||
| Line 311: | Line 347: | ||
* [[Levobetaxolol]] | * [[Levobetaxolol]] | ||
* [[Levobunolol]] | * [[Levobunolol]] | ||
| − | |||
* [[Levomoprolol]] | * [[Levomoprolol]] | ||
* [[Medroxalol]] | * [[Medroxalol]] | ||
* [[Mepindolol]] | * [[Mepindolol]] | ||
| − | |||
* [[Metipranolol]] | * [[Metipranolol]] | ||
* [[Metoprolol]] | * [[Metoprolol]] | ||
| Line 321: | Line 355: | ||
* [[Nadolol]] | * [[Nadolol]] | ||
* [[Nadoxolol]] | * [[Nadoxolol]] | ||
| − | |||
* [[Nebivolol]] | * [[Nebivolol]] | ||
| − | |||
* [[Nifenalol]] | * [[Nifenalol]] | ||
* [[Nipradilol]] | * [[Nipradilol]] | ||
| − | |||
* [[Oxprenolol]] | * [[Oxprenolol]] | ||
* [[Pacrinolol]] | * [[Pacrinolol]] | ||
| Line 332: | Line 363: | ||
* [[Pamatolol]] | * [[Pamatolol]] | ||
* [[Pargolol]] | * [[Pargolol]] | ||
| − | |||
* [[Penbutolol]] | * [[Penbutolol]] | ||
| − | |||
| − | |||
* [[Pindolol]] | * [[Pindolol]] | ||
| − | |||
* [[Practolol]] | * [[Practolol]] | ||
* [[Primidolol]] | * [[Primidolol]] | ||
| Line 351: | Line 378: | ||
* [[SR 59230A]] | * [[SR 59230A]] | ||
* [[Sulfinalol]] | * [[Sulfinalol]] | ||
| − | |||
* [[Talinolol]] | * [[Talinolol]] | ||
* [[Tazolol]] | * [[Tazolol]] | ||
| − | |||
* [[Tertatolol]] | * [[Tertatolol]] | ||
| − | |||
* [[Tienoxolol]] | * [[Tienoxolol]] | ||
* [[Tilisolol]] | * [[Tilisolol]] | ||
| Line 363: | Line 387: | ||
* [[Tolamolol]] | * [[Tolamolol]] | ||
* [[Toliprolol]] | * [[Toliprolol]] | ||
| − | |||
| − | |||
* [[Xibenolol]] | * [[Xibenolol]] | ||
* [[Xipranolol]] | * [[Xipranolol]] | ||
| − | + | |group4 = See<br/>also | |
| − | + | |list4 = *[[List of adrenergic drugs]] | |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | * [[ | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | }}<noinclude>[[Category:Drug templates by receptor, channel, or pump]]</noinclude> | + | }}<noinclude> |
| + | {{documentation | content = | ||
| + | {{collapsible option}} | ||
| + | [[Category:Drug templates by receptor, channel, or pump]] | ||
| + | }}</noinclude> | ||
Latest revision as of 10:17, 18 October 2020
50px Template documentation
Initial visibility: currently defaults to autocollapse
To set this template's initial visibility, the |state= parameter may be used:
|state=collapsed:{{Adrenergic receptor modulators|state=collapsed}}to show the template collapsed, i.e., hidden apart from its title bar|state=expanded:{{Adrenergic receptor modulators|state=expanded}}to show the template expanded, i.e., fully visible|state=autocollapse:{{Adrenergic receptor modulators|state=autocollapse}}
If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.
| Editors can experiment in this template's sandbox (edit | diff) and testcases (create) pages. Subpages of this template. |